Post by Dana-Farber Cancer Institute

While many physician-scientists have attempted to treat glioblastoma, it remains one of the most difficult human cancer types to manage. “Even though glioblastoma is an aggressive brain cancer, it does not trigger an aggressive immune response,” says Kai Wucherpfennig, MD, PhD, chair of Cancer Immunology and Virology. “We call this a ‘cold tumor,’ which makes it difficult to treat.” Learn more about how researchers are changing the trajectory of brain cancer with a stronger immune defense: https://bit.ly/3PS3fwa